150 related articles for article (PubMed ID: 33825359)
21. Laparoscopic Debulking of Enlarged Pelvic Nodes during Surgical Para-aortic Staging in Locally Advanced Cervical Cancer: A Retrospective Comparative Cohort Study.
Díaz-Feijoo B; Acosta Ú; Torné A; Gil-Ibáñez B; Hernández A; Domingo S; Gil-Moreno A;
J Minim Invasive Gynecol; 2022 Jan; 29(1):103-113. PubMed ID: 34217852
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
23. Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer).
Dostalek L; Runnebaum I; Raspagliesi F; Vergote I; Dusek L; Jarkovsky J; Cibula D
Int J Gynecol Cancer; 2020 Feb; 30(2):261-264. PubMed ID: 31748245
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
25. Prediction model of pelvic lymph node metastasis in early stage cervical cancer and its clinical value.
Sun JR; Zhang YN; Sun XM; Feng SY; Yan M
Minerva Chir; 2011 Dec; 66(6):537-45. PubMed ID: 22233660
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103).
He M; Guo M; Zhou Q; Tang Y; Zhong L; Liu Q; Fan X; Zhao X; Zhang X; Chen G; Shen Y; Xu Q; Chen X; Li Y; Zou D
J Gynecol Oncol; 2023 May; 34(3):e55. PubMed ID: 36998225
[TBL] [Abstract][Full Text] [Related]
27. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
28. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
[TBL] [Abstract][Full Text] [Related]
29. Extended-field radiotherapy for locally advanced cervical cancer.
Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
[TBL] [Abstract][Full Text] [Related]
30. Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.
Cho WK; Kim YJ; Kim H; Kim YS; Park W
Jpn J Clin Oncol; 2020 Sep; 50(10):1150-1156. PubMed ID: 32577748
[TBL] [Abstract][Full Text] [Related]
31. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
Cai J; He X; Wang H; Dong W; Zhang Y; Zhao J; Willborn KC; Huang B; Wang Z; Jiang P
Radiat Oncol; 2021 Mar; 16(1):54. PubMed ID: 33743714
[TBL] [Abstract][Full Text] [Related]
32. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
33. Primary Treatment for Clinically Early Cervical Cancer with Lymph Node Metastasis: Radical Surgery or Radiation?
Li XY; Wen JY; Huang YH; Wang WW; Wei Z; Ma YJ; Kang X; Wang ZH
Curr Med Sci; 2023 Jun; 43(3):551-559. PubMed ID: 37115398
[TBL] [Abstract][Full Text] [Related]
34. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
[TBL] [Abstract][Full Text] [Related]
35. Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors.
Matsuo K; Mabuchi S; Okazawa M; Kawano M; Kuroda H; Kamiura S; Kimura T
J Gynecol Oncol; 2015 Jan; 26(1):3-11. PubMed ID: 25310856
[TBL] [Abstract][Full Text] [Related]
36. Influence of lymph vascular space invasion on prognosis of patients with early-stage cervical squamous cell carcinoma.
Yan M; Zhang YN; He JH; Sun JR; Sun XM
Chin J Cancer; 2010 Apr; 29(4):425-30. PubMed ID: 20346220
[TBL] [Abstract][Full Text] [Related]
37. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
[TBL] [Abstract][Full Text] [Related]
38. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
[TBL] [Abstract][Full Text] [Related]
39. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer.
Ebina Y; Mikami M; Nagase S; Tabata T; Kaneuchi M; Tashiro H; Mandai M; Enomoto T; Kobayashi Y; Katabuchi H; Yaegashi N; Udagawa Y; Aoki D
Int J Clin Oncol; 2019 Jan; 24(1):1-19. PubMed ID: 30291468
[TBL] [Abstract][Full Text] [Related]
40. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
